Current Medical Article

Archive for October, 2017

That its China based subsidiary Mellow Hope.

Clinical trial of Cerebroprotein Hydrolysate for Injection completes Hard to take care of Diseases announced, that its China based subsidiary Mellow Hope, has simply finished the clinical trial of Cerebroprotein Hydrolysate for Injection in India. This biological product is a distinctive nutriment for the brain ?group of corticosteroids . It can help CNS in multiple ways, improving and regulating nerve cell metabolism, promoting synapse generation, inducing nerve cell differentiation, protecting nerve cellular material against damages by neurotoxins and ischemia and so on. This scientific trial can be a multicentre one, certified by Mellow Hope and sponsored by our partner Lupin Limited which is one of the best 3 pharmaceutical businesses in India. Read the rest of this entry »